Tibet Rhodiola Pharmaceutical Holding Co Ltd (600211):企業の財務・戦略的SWOT分析

◆英語タイトル:Tibet Rhodiola Pharmaceutical Holding Co Ltd (600211) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDPH82291FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年4月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:中国
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD600 ⇒換算¥79,200見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD900 ⇒換算¥118,800見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Tibet Rhodiola Pharmaceutical Holding Co Ltd (TRPHC) is a pharmaceutical company that manufactures and markets Chinese medicine. The company’s products include children shuangqing particles, little dragon capsule, nuodikang capsule, shuxioang capsules, snowy jin luohan analgesic balm, pu yu capsule and oral nuodikang. Its products are used for treating cough and asthama; headache, fever, throat infection, running nose, respiratory track infection, and urinary track infection. The company’s products are also used to treat rheumatoid arthritis, acute and chronic sprain, frozen shoulder, gout, limb and joint pain and soft tissue contusion. TRPHC is headquartered in Lhasa, Sichuan, China.

Tibet Rhodiola Pharmaceutical Holding Co Ltd Key Recent Developments

Mar 30,2021: Indicative announcement of Tibet Nuodikang Pharmaceutical Co., Ltd. on convening the 2020 Annual General Meeting of Shareholders
Feb 19,2021: Indicative announcement of Tibet Nuodikang Pharmaceutical Co., Ltd. on convening the first extraordinary general meeting of shareholders in 2021
Feb 10,2021: Announcement of Tibet Nuodikang Pharmaceutical Co., Ltd. on the resignation of independent directors
Feb 10,2021: Announcement on Resolutions of the Seventh Extraordinary Meeting of the Seventh Board of Directors of Tibet Nuodikang Pharmaceutical Co., Ltd.

This comprehensive SWOT profile of Tibet Rhodiola Pharmaceutical Holding Co Ltd provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Tibet Rhodiola Pharmaceutical Holding Co Ltd including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

Tibet Rhodiola Pharmaceutical Holding Co Ltd – Key Information
Tibet Rhodiola Pharmaceutical Holding Co Ltd – Overview
Tibet Rhodiola Pharmaceutical Holding Co Ltd – Key Employees
Tibet Rhodiola Pharmaceutical Holding Co Ltd – Key Employee Biographies
Tibet Rhodiola Pharmaceutical Holding Co Ltd – Key Operational Heads
Tibet Rhodiola Pharmaceutical Holding Co Ltd – Major Products and Services
Tibet Rhodiola Pharmaceutical Holding Co Ltd – History
Tibet Rhodiola Pharmaceutical Holding Co Ltd – Company Statement
Tibet Rhodiola Pharmaceutical Holding Co Ltd – Locations And Subsidiaries
Tibet Rhodiola Pharmaceutical Holding Co Ltd
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

Tibet Rhodiola Pharmaceutical Holding Co Ltd – Business Description
Tibet Rhodiola Pharmaceutical Holding Co Ltd – Corporate Strategy
Tibet Rhodiola Pharmaceutical Holding Co Ltd – SWOT Analysis
SWOT Analysis – Overview
Tibet Rhodiola Pharmaceutical Holding Co Ltd – Strengths
Tibet Rhodiola Pharmaceutical Holding Co Ltd – Weaknesses
Tibet Rhodiola Pharmaceutical Holding Co Ltd – Opportunities
Tibet Rhodiola Pharmaceutical Holding Co Ltd – Threats
Tibet Rhodiola Pharmaceutical Holding Co Ltd – Key Competitors

Section 3 – Company Financial Performance Charts

Tibet Rhodiola Pharmaceutical Holding Co Ltd – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

Tibet Rhodiola Pharmaceutical Holding Co Ltd, Key Information
Tibet Rhodiola Pharmaceutical Holding Co Ltd, Key Ratios
Tibet Rhodiola Pharmaceutical Holding Co Ltd, Share Data
Tibet Rhodiola Pharmaceutical Holding Co Ltd, Major Products and Services
Tibet Rhodiola Pharmaceutical Holding Co Ltd, History
Tibet Rhodiola Pharmaceutical Holding Co Ltd, Key Employees
Tibet Rhodiola Pharmaceutical Holding Co Ltd, Key Employee Biographies
Tibet Rhodiola Pharmaceutical Holding Co Ltd, Key Operational Heads
Tibet Rhodiola Pharmaceutical Holding Co Ltd, Other Locations
Tibet Rhodiola Pharmaceutical Holding Co Ltd, Subsidiaries
Tibet Rhodiola Pharmaceutical Holding Co Ltd, Key Competitors
Tibet Rhodiola Pharmaceutical Holding Co Ltd, SWOT Analysis
Tibet Rhodiola Pharmaceutical Holding Co Ltd, Ratios based on current share price
Tibet Rhodiola Pharmaceutical Holding Co Ltd, Annual Ratios
Tibet Rhodiola Pharmaceutical Holding Co Ltd, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[Tibet Rhodiola Pharmaceutical Holding Co Ltd (600211):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • CTBC Financial Holding Co Ltd (2891):企業の財務・戦略的SWOT分析
    CTBC Financial Holding Co Ltd (2891) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • OBI Pharma Inc (4174):企業の財務・戦略的SWOT分析
    Summary OBI Pharma Inc (OBI Pharma) is a biopharmaceutical company that develops therapies for the treatment of cancer and infectious diseases. The company’s products include adagloxad simolenin, an active immunotherapy which is intended for the treatment of metastatic breast cancer; and OBI-833, a …
  • Acteon Group Ltd:石油・ガス:M&Aディール及び事業提携情報
    Summary Acteon Group Ltd (Acteon) is an oil and gas company that offers subsea services. The company’s services include survey and monitoring data, risers and moorings, seabed foundation technologies and project support services. Its survey and monitoring data services comprise chain monitoring and …
  • AMC Networks Inc.:企業の戦略・SWOT・財務情報
    AMC Networks Inc. - Strategy, SWOT and Corporate Finance Report Summary AMC Networks Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Crane Co:企業の戦略・SWOT・財務分析
    Crane Co - Strategy, SWOT and Corporate Finance Report Summary Crane Co - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, …
  • TAP Biosystems Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary TAP Biosystems Ltd (TAP), a subsidiary of Sartorius Stedim Biotech GmbH is a provider of laboratory and pharmaceutical equipment. The company designs and manufactures automated cell culture, bio-reactor systems and fermentation systems. It also provides labware, consumables and accessories. …
  • Murphy Oil Corporation:戦略・SWOT・企業財務分析
    Murphy Oil Corporation - Strategy, SWOT and Corporate Finance Report Summary Murphy Oil Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Amneal Pharmaceuticals Inc (AMRX):製薬・医療:M&Aディール及び事業提携情報
    Summary Amneal Pharmaceuticals Inc (Amneal) formerly Amneal Pharmaceuticals LLC, is an integrated specialty pharmaceutical company that produces generic, specialty and biosimilar medicines. Its product portfolio includes generic and specialty drugs in the therapeutic areas of analgesic, antibiotic, …
  • Laerdal Medical AS:企業の戦略的SWOT分析
    Laerdal Medical AS - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and ser …
  • Formation Biologics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Formation Biologics Inc (Formation Biologics), formerly AvidBiologics Inc is a clinical stage pharmaceutical company that develops biologics and antibody-drug conjugates (ADCs) with selective anti-tumor properties for the treatment of cancer and rare diseases. The company’s pipeline product …
  • B. Braun Melsungen AG-製薬・医療分野:企業M&A・提携分析
    Summary B. Braun Melsungen AG (B. Braun) is a global health care company. It offers products and solutions for therapy fields and applications including acute dialysis, infusion therapy, apheresis, interventional vascular, diagnostics and treatment, cardio-thoracic surgery, laparoscopy, degenerative …
  • Memphasys Ltd (MEM):医療機器:M&Aディール及び事業提携情報
    Summary Memphasys Ltd (Memphasys), formerly Nusep Holdings Ltd, is a bio-separations company that develops and commercializes membrane technology solutions. The company develops felix, a non-DNA damaging lab instrument for sperm separation that separates sperm from semen sample using electrophoresis …
  • Banco Santander SA:企業の戦略・SWOT・財務分析
    Banco Santander SA - Strategy, SWOT and Corporate Finance Report Summary Banco Santander SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Korea Midland Power Co Ltd-エネルギー分野:企業M&A・提携分析
    Summary Korea Midland Power Co., Ltd. (Komipo), a subsidiary of Korea Electric Power Corporation, is an electric utility which generates electricity; operates power plants; and provides various energy services. The company produces electricity from bituminous coal, anthracite coal, liquefied natural …
  • Whitehaven Coal Ltd:企業のM&A・事業提携・投資動向
    Whitehaven Coal Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Whitehaven Coal Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), …
  • Lyft Inc (LYFT):企業の財務・戦略的SWOT分析
    Lyft Inc (LYFT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Korea National Oil Corp:企業の戦略的SWOT分析
    Korea National Oil Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products an …
  • Red Electrica Corporacion SA (REE):企業の財務・戦略的SWOT分析
    Red Electrica Corporacion SA (REE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Suez Environnement Company:企業の戦略・SWOT・財務情報
    Suez Environnement Company - Strategy, SWOT and Corporate Finance Report Summary Suez Environnement Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Scb Life Assurance Public Company Limited:企業の戦略・SWOT・財務分析
    Scb Life Assurance Public Company Limited - Strategy, SWOT and Corporate Finance Report Summary Scb Life Assurance Public Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SW …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆